EquityFlow
›
Companies
› Speclipse
Speclipse
Healthtech
· Seoul, KR
Non-invasive skin-cancer diagnosis using laser spectroscopy and AI (Spectra-Scope)
Funding history
Date
Round
Amount
Aug 2021
Funding round
Speclipse, a Korean medical-diagnostics company (Spectra-Scope), raised KRW 9B.
—
Similar companies in Healthtech
OurMind
TurnUp
Nanordica Medical
Uncovr
01Health
Rem3dy Health
Joyvié Health
Semble
Triomics
Musely
VITL
Ema Health
Explore funding flow on EquityFlow →